Impact of early tumor shrinkage on quality of life in patients treated with first-line cetuximab plus chemotherapy for unresectable metastatic colorectal cancer: results of Phase II QUACK trial
暂无分享,去创建一个
M. Ando | Masato Nakamura | J. Sakamoto | Y. Miyake | Y. Hashiguchi | K. Yamaguchi | A. Tsuji | M. Ishikawa | H. Hara | M. Kotaka | S. Iwamoto | H. Satake | A. Ooki | T. Shingai | T. Suto | H. Tanioka | M. Kataoka | Taichi Yabuno | S. Morita | Y. Kagawa